Fluvoxamine maleate and Sick sinus syndrome - a phase IV clinical study of FDA data

Summary:

Sick sinus syndrome is reported only by a few people who take Fluvoxamine Maleate.

The phase IV clinical study analyzes which people take Fluvoxamine maleate and have Sick sinus syndrome. It is created by eHealthMe based on reports of 3,146 people who have side effects while taking Fluvoxamine maleate from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 28, 2022

3,146 people reported to have side effects when taking Fluvoxamine maleate.
Among them, 4 people (0.13%) have Sick sinus syndrome.

What is Fluvoxamine maleate?

Fluvoxamine maleate has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 3,467 Fluvoxamine maleate users for its effectiveness, alternative drugs and more.

What is Sick sinus syndrome?

Sick sinus syndrome (a collection of heart rhythm disorders) is found to be associated with 1,317 drugs and 738 conditions by eHealthMe.

Number of Fluvoxamine maleate and Sick sinus syndrome reports submitted per year:

Could Fluvoxamine maleate cause Sick sinus syndrome?

Gender of people who have Sick sinus syndrome when taking Fluvoxamine maleate *:

female: 100 %
male: 0.0 %

Age of people who have Sick sinus syndrome when taking Fluvoxamine maleate *:

Common drugs people take besides Fluvoxamine maleate *:

Common side effects people have besides Sick sinus syndrome *:

Hypotension (abnormally low blood pressure): 3 people, 75.00%
Nausea (feeling of having an urge to vomit): 2 people, 50.00%
Kleptomania (the urge to steal items for reasons other than personal use or financial gain): 2 people, 50.00%
Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 1 person, 25.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 25.00%
Fatigue (feeling of tiredness): 1 person, 25.00%
Cardiac Output Decreased: 1 person, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fluvoxamine maleate and have Sick sinus syndrome?

Check whether Sick sinus syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

Related studies

Common Fluvoxamine maleate side effects:

Browse all side effects of Fluvoxamine maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sick sinus syndrome treatments and more:

Sick sinus syndrome (4,287 reports)

COVID vaccines that are related to Sick sinus syndrome:

Common drugs associated with Sick sinus syndrome:

All the drugs that are associated with Sick sinus syndrome:

Sick sinus syndrome (1,317 drugs)

Common conditions associated with Sick sinus syndrome:

High blood pressure: 446 reports
Atrial fibrillation/flutter: 307 reports
Diabetes: 217 reports
Multiple myeloma: 158 reports
Osteoporosis: 154 reports
Type 2 diabetes: 122 reports

All the conditions that are associated with Sick sinus syndrome:

Sick sinus syndrome (738 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluvoxamine maleate (the active ingredients of Fluvoxamine maleate) and Fluvoxamine maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.